Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1988 1
1993 1
1994 1
1995 2
1997 1
1998 5
1999 1
2000 4
2001 4
2002 6
2003 10
2004 7
2005 4
2006 8
2007 5
2008 5
2009 8
2010 2
2011 3
2012 8
2013 5
2014 4
2015 3
2018 2
2019 1
2020 2
2023 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the health benefits of outdoor exercise for cancer survivors: a systematic review of more than 700 individuals.
Ortega-Gómez S, Di Bartolo L, Velissari J, Gomes B, Pusa S, Thaller J, Papakonstantinou S, Kirkar M, Iannitto E, Moura N, Nogueira C, Ponce-González JG, Baxter R, Tavares P, Vantarakis A, Bianco A, Carbonell-Baeza A, Jiménez-Pavón D; OACCUs consortium. Ortega-Gómez S, et al. Among authors: iannitto e. Syst Rev. 2025 May 7;14(1):101. doi: 10.1186/s13643-025-02834-y. Syst Rev. 2025. PMID: 40336008 Free PMC article.
Erratum to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C. Iannitto E, et al. Haematologica. 2025 Apr 1;110(4):1048-1049. doi: 10.3324/haematol.2024.287031. Epub 2025 Apr 1. Haematologica. 2025. PMID: 40165734 Free PMC article. No abstract available.
Experiences, behaviours, and perspectives of young cancer survivors on physical activity.
Thomas E, Di Bartolo L, Galioto M, Seminara D, Pusa S, Baxter R, Ortega-Gómez S, Jiménez-Pavón D, Vasilopoulou M, Vantarakis A, Tavares P, Campos MJ, Thaller P, Thaller J, Papakonstantinou S, Kirkar M, Vivirito S, Glorioso F, Iannitto E, Lo Mauro M, Bianco A. Thomas E, et al. Among authors: iannitto e. Heliyon. 2024 Aug 3;10(15):e35732. doi: 10.1016/j.heliyon.2024.e35732. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170495 Free PMC article. Review.
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C. Iannitto E, et al. Haematologica. 2024 Jul 1;109(7):2297-2302. doi: 10.3324/haematol.2023.284109. Haematologica. 2024. PMID: 38497158 Free PMC article. Clinical Trial. No abstract available.
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
André MPE, Carde P, Viviani S, Bellei M, Fortpied C, Hutchings M, Gianni AM, Brice P, Casasnovas O, Gobbi PG, Zinzani PL, Dupuis J, Iannitto E, Rambaldi A, Brière J, Clément-Filliatre L, Heczko M, Valagussa P, Douxfils J, Depaus J, Federico M, Mounier N. André MPE, et al. Among authors: iannitto e. Cancer Med. 2020 Sep;9(18):6565-6575. doi: 10.1002/cam4.3298. Epub 2020 Jul 25. Cancer Med. 2020. PMID: 32710498 Free PMC article. Review.
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study.
Iannitto E, Romano A, Scalzulli PR, Bonanno V, Scalone R, Chiarenza A, Pirosa MC, Caruso AL, Minoia C, Mantuano S, De Santis G, Salerno M, Crescimanno A, Porretto F, Li Gioi F, Ricciuti G, Greco A, Pavone E, Guarini A, Tarantini G, Mannina D, Consoli U, Cascavilla N, Di Raimondo F, Musso M. Iannitto E, et al. Eur J Haematol. 2020 Jun;104(6):581-587. doi: 10.1111/ejh.13400. Epub 2020 Mar 13. Eur J Haematol. 2020. PMID: 32107795
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Iannitto E, Bellei M, Amorim S, Ferreri AJM, Marcheselli L, Cesaretti M, Haioun C, Mancuso S, Bouabdallah K, Gressin R, Tripodo C, Traverse-Glehen A, Baseggio L, Zupo S, Stelitano C, Castagnari B, Patti C, Alvarez I, Liberati AM, Merli M, Gini G, Cabras MG, Dupuis J, Tessoulin B, Perrot A, Re F, Palombi F, Gulino A, Zucca E, Federico M, Thieblemont C. Iannitto E, et al. Br J Haematol. 2018 Dec;183(5):755-765. doi: 10.1111/bjh.15641. Epub 2018 Nov 8. Br J Haematol. 2018. PMID: 30407629 Clinical Trial.
102 results